Genitourinary Cancers Special Issue 2020 | CURE

October 04, 2020

Finding balance to detect and treat prostate cancer without overtreatment is important for patients.

October 03, 2020

PARP inhibitors are not only expanding the field of prostate cancer but they're giving men another option for life after cancer.

October 02, 2020

After a recommendation against routine prostate cancer screening, rates of early disease declined while the incidence of advanced disease rose. The trend highlights the difficult balance between screening and potential overtreatment.

October 01, 2020

Primed to knock out cells vulnerable due to DNA-repair problems, PARP inhibitors are ushering in a targeted-drug era in prostate cancer treatment.

October 01, 2020

For some patients with metastatic kidney cancer, undergoing surgery after targeted or immune therapy sparks better health outcomes.

September 30, 2020

Patients with advanced or metastatic bladder cancer, after responding to initial treatment with chemotherapy, may preserve their health improvements by starting immunotherapy immediately.

September 30, 2020

After treatment for bladder or prostate cancer, many survivors confront permanent sexual side effects. The good news is that treatments and psychological support are available.

September 29, 2020

A growing number of treatments are available to men whose prostate cancer has spread and become resistant to hormonal therapy.

September 29, 2020

A woman shares her late husband’s journey with advanced penile cancer to help others receive a diagnosis early, when the disease is still highly treatable and even curable.

September 28, 2020

After enjoying visits from therapy dogs during treatment for testicular cancer, a student pilot decides to volunteer to transport pets needing rescue, shelter or adoption.

September 28, 2020

Forward Momentum, a coalition launched by a biopharmaceutical company and three partners, focuses on the health disparities faced by Black men with prostate cancer.